Ophthalmology

Medical industries company receives approval for ultrasound biomicroscope

Published in Medical Letter on the CDC and FDA, July 3rd, 2005

Paradigm Medical Industries, Inc., (PMED) announced it has received U.S. Food and Drug Administration (FDA) 510(k) premarket approval for its P60 ultrasound biomicroscope (UBM). The UBM is used for viewing structures in the eye involved with glaucoma pathologies and surgical procedures.

"FDA approval will allow the company to begin selling the P60 in the U.S. immediately," said Paradigm Medical's chief operating officer, Aziz A. Mohabbat. "Coupled with receiving the CE Mark earlier this year, the company can now participate in the global market opportunity for UBM devices."

The P60 represents the company's fourth-generation of UBM devices, and is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2005-07-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry